Skip to main content
. 2018 Apr 13;15(6):9572–9576. doi: 10.3892/ol.2018.8482

Table III.

Drug resistance to cisplatin of 60 ovarian cancer patients.

Groups Case (n) Ratio (%)
Drug-resistance 38 63.33
Sensitive 22 36.67